Rachamala, Hari K.
Madamsetty, Vijay S.
Angom, Ramcharan S.
Nakka, Naga M.
Dutta, Shamit Kumar
Wang, Enfeng
Mukhopadhyay, Debabrata
Pal, Krishnendu
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-21-1-0678)
National Cancer Institute (CA78383, CA150190)
Article History
Received: 18 December 2023
Accepted: 24 May 2024
First Online: 6 June 2024
Declarations
:
: All animal work was performed following the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) guidelines under protocols approved by the Mayo Clinic Institutional Animal Care and Use Committee (IACUC).
: All authors read and approved the final manuscript.
: DM, VSM, and KP have applied for the protection of intellectual property for the tumor-targeted liposomal formulation described in the manuscript. There are no other conflicts of interest to declare.